Free Trial

Addus HomeCare Co. (NASDAQ:ADUS) Shares Purchased by Nebula Research & Development LLC

Addus HomeCare logo with Medical background

Nebula Research & Development LLC grew its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 90.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 14,225 shares of the company's stock after buying an additional 6,757 shares during the quarter. Nebula Research & Development LLC owned 0.08% of Addus HomeCare worth $1,783,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Oberweis Asset Management Inc. grew its stake in Addus HomeCare by 23.5% in the 4th quarter. Oberweis Asset Management Inc. now owns 59,900 shares of the company's stock worth $7,508,000 after acquiring an additional 11,400 shares in the last quarter. Voya Investment Management LLC grew its stake in Addus HomeCare by 1.7% in the fourth quarter. Voya Investment Management LLC now owns 224,559 shares of the company's stock worth $28,148,000 after purchasing an additional 3,855 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Addus HomeCare by 0.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 226,636 shares of the company's stock worth $28,410,000 after purchasing an additional 1,087 shares during the period. Massar Capital Management LP purchased a new stake in shares of Addus HomeCare in the 4th quarter worth $381,000. Finally, IHT Wealth Management LLC raised its holdings in shares of Addus HomeCare by 51.5% in the fourth quarter. IHT Wealth Management LLC now owns 4,402 shares of the company's stock valued at $552,000 after acquiring an additional 1,496 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ADUS has been the subject of several analyst reports. StockNews.com lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Oppenheimer increased their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Macquarie restated an "outperform" rating and set a $129.00 target price on shares of Addus HomeCare in a research report on Thursday, February 27th. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Tuesday, April 22nd. Finally, Stephens reissued an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. One analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Buy" and an average price target of $139.00.

Read Our Latest Analysis on ADUS

Addus HomeCare Stock Performance

Shares of ADUS traded down $0.32 during trading hours on Thursday, hitting $104.24. 114,743 shares of the stock were exchanged, compared to its average volume of 162,785. Addus HomeCare Co. has a 12-month low of $88.96 and a 12-month high of $136.72. The company has a market cap of $1.89 billion, a price-to-earnings ratio of 23.82, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. The stock's 50-day moving average price is $97.41 and its two-hundred day moving average price is $115.61.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. On average, research analysts expect that Addus HomeCare Co. will post 4.59 earnings per share for the current year.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines